UK Markets open in 38 mins

Stratec SE (STSEY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
26.250.00 (0.00%)
At close: 09:10AM EST

Stratec SE

Gewerbestrasse 35-37
Birkenfeld 75217
49 7082 7916 0

IndustryMedical Devices
Full-time employees1,400

Key executives

NameTitlePayExercisedYear born
Mr. Marcus WolfingerChairman of Board of Management & CEO829.99kN/A1967
Dr. Robert SiegleDirector of Fin. & HR and Member of Board of Management664.46kN/A1967
Dr. Claus VielsackDirector of Product Devel. & Member of Board of Management568.2kN/A1967
Mr. Hermann LeistnerFounder & AdvisorN/AN/A1946
Mr. Jan KeppelerHead of Investor Relations & Corp. CommunicationsN/AN/AN/A
Mr. Andre LoyDirector of Corp. CommunicationsN/AN/AN/A
Mr. Roland UtzHead of Supply Chain Management & Sr. VPN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Corporate governance

Stratec SE’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.